Email not displaying correctly? View it in your browser
Forward to a colleague | Sign up to BNF eNews
BNF BNF for Children Medicines Complete
September 2017 Share this issue Facebook LinkedIn Twitter
 
I Welcome
Welcome to the September BNF eNewsletter.
BNF 74 - available this month!
This month sees the publication of the new BNF 74 & BNFC 2017-2018. Read on for more details and order your copies now!

BNF publications will also be attending this year's Pharmacy Show at the NEC in Birmingham, 8th & 9th October. At this year's annual show, we will be featuring our new print titles and talking about the new interactions content due to launch very soon. Visit us at stand PJ43 to learn more!

Thirteen new drug monographs have been added to the BNF in the last month, including - bezlotoxumab, cabozantinib, eluxadoline, olaratumab, obeticholic acid and, rolapitant. We have included dose changes for tinzaparin sodium (Innohep®): clarification of indication for extended treatment of venous thromboembolism and prevention of recurrence in patients with active cancer.

This issue highlights new guidance on premature ejaculation, cerebral palsy and spasticity, updated guidance on neural tube defects (prevention in pregnancy) and, management of diabetes (pregnancy and breast-feeding). We also include MHRA advice on reports of organ transplant rejection with nivolumab and pembrolizumab and, NICE technology appraisals for daclizumab for treating relapsing-remitting multiple sclerosis.
Kind regards,
BNF Team
I In this issue
New interactions More >  
BNF 74 available More >  
Significant changes More >  
News More >  
How to purchase BNF More >  
Price reminder More >  
Drug safety update More >  
Feedback More >  
I BNF & BNF For Children: New interactions
In October 2017, we will be launching new interactions content for the BNF. Driven by user feedback we will introduce the following changes:

Increased coverage and a greater focus on the clinical relevance of the interactions
A consistent style and terminology across all BNF Publications
A new grading system for both severity of the interaction and the evidence to support it

Please also note that the full set of legacy BNF content will no longer be available from October. For any users who wish to view the previous chapter structure, the legacy hierarchy will remain visible.

To find out more, please visit BNF.org.
BNF BNF 74 available to order now!
BNF 74 has been revised and updated to reflect best practice as well as up-to-date legal and professional guidelines relating to the uses of medicines. Access to the latest edition is vital for healthcare professionals, giving reliable guidance on prescribing, dispensing, and administering medicines.

New content updates include:
New guidance on motor neurone disease, pre-exposure prophylaxis for HIV infection, low back pain and sciatica.
Updated guidance for conditions including cholestasis, Crohn’s disease, constipation, interactions with contraceptives, diabetes.
New drug monographs including amsacrine, ataluren, baricitinib, camellia sinensis, dalbavancin, daratumumab, etelcalcetide, idebenone.
New safety information on brimonidine gel and the risk of systemic cardiovascular effects, denosumab and reports of osteonecrosis of the external auditory canal.
Updated advice on the risk of diabetic ketoacidosis with sodium-glucose co-transporter 2 inhibitors.
Significant dose changes including fenofibrate in renal impairment and medroxyprogesterone acetate: hot flushes caused by long-term androgen suppression in men with prostate cancer [unlicensed use].
 
Find out more and order BNF 74 here.
BNF 71

ISBN: 978 0 85711 298 9
September 2017 • Paperback • 1,552pp

BNF New BNF for Children 2017-2018
The BNF for Children (BNFC) provides essential, practical information to all healthcare professionals involving in the prescribing, dispensing, monitoring and administration of medicines to children.

Significant new content updates include:
New guidance on management of anal fissure and haemorrhoids.
Updated guidance on contraceptives (interactions), Crohn’s disease, diabetes, food allergy, nocturnal enuresis in children, Smith-Lemli-Opitz syndrome, tuberculosis ulcerative colitis, urinary retention.
New drug monographs including asparaginase, ataluren, dexamethasone with ciprofloxacin, eltrombopag, idebenone, pegaspargase.
New safety information on hyoscine butylbromide injection: risk of serious adverse effects in patients with underlying cardiac disease (MHRA advice) and patient safety alert for valproate: resources to support the safety of girls and women who are being treated with valproate (NHS improvement patient safety alert).
Updated advice on acetylcysteine: intravenous acetylcysteine for paracetamol overdose: reminder of authorised dose regimen; possible need for continued treatment (MHRA advice).
Significant dose changes including nystatin for oral candidiasis.
 
Find out more and order BNFC here.
BNF 71

ISBN: 978 0 85711 248 4
September 2017 • Paperback • 1,072pp

I Significant
changes
This month's changes to the clinical content of these publications are described in three parts:

BNF and BNFC update should be read by all users
BNF update should be read by all users of the BNF
BNFC update should be read by all users of the BNF for Children
BNF 72 - BNFC 2016-2017
BNF Update
Cabozantinib: new drug monograph
For further information, see cabozantinib.
Eluxadoline: new drug monograph
For further information, see eluxadoline.
Obeticholic acid: new drug monograph
For further information, see obeticholic acid.
Olaratumab: new drug monograph
For further information, see olaratumab.
Premature ejaculation: new guidance on management
For further information, see premature ejaculation
Dose changes
Tinzaparin sodium (Innohep®): clarification of indication for extended treatment of venous thromboembolism and prevention of recurrence in patients with active cancer
For further information, see tinzaparin sodium.
Other changes
To review other changes in the BNF, click on changes.
BNF BNF for Children Update
Rupatadine: new drug monograph
For further information, see rupatadine.
Neural tube defects (prevention in pregnancy): updated guidance on management
For further information, see neural tube defects (prevention in pregnancy).
Diabetes, pregnancy and breast-feeding: updated guidance on management
For further information, see diabetes, pregnancy and breast-feeding.
BNF for Children Update
Cerebral palsy and spasticity: new guidance on management
For further information, see cerebral palsy and spasticity.
Other changes
To review other changes in BNF for Children, click on changes.
I News
Reminder - help from CPPE with BNF 73
An interactive PDF e-learning programme from the Centre for Pharmacy Postgraduate Education (CPPE) will help you familiarise yourself with recommendations in BNF 73. It comprises 10 practical case studies, and can be accessed here.
BNF 73
I How to purchase BNF
Purchase Print copies
Purchase print copies
To order the September 2017 edition, visit the Pharmaceutical Press website.
More
Purchase a print subscription
Purchase a print subscription and save money
A print subscription is the best way to ensure access to the latest copy of BNF as soon as it publishes.
More
BNF online
BNF online
Outside the UK, content is available via a subscription to MedicinesComplete.
Email us
BNF eBook
BNF eBook
BNF is also available as a PDF eBook.
More
I Monthly price update reminder
Prices of all branded medicinal products in the BNF and BNFC are now updated monthly. Prices of generic preparations of medicinal products are updated every 2-4 months, to coincide with print editions of BNF and BNF for Children. The BNF team keeps price information up to date using data sourced from the NHS dictionary of medicines and devices (dm+d).
Drug Safety Update
Drug Safety Update is a monthly newsletter from
the MHRA and Commission on Human Medicine.
Please follow this link to review this month's Drug Safety Update.
I Feedback on our eNewsletter
Please let us know if there are any issues that you'd like us to address in our eNewsletters. We welcome your feedback. If you have any comments or suggestions, please let us know at marketing@rpharms.com.
Subscribe to this eNewsletter here
I Related Products
Medicines Complete BNF Pharmaceutical Press
BNF
Copyright © 2017 BMJ Publishing Group Ltd and the Royal Pharmaceutical Society of Great Britain. All rights reserved. Terms of use.
BNF for Children
Copyright © 2017 BMJ Publishing Group Ltd, the Royal Pharmaceutical Society of Great Britain and RCPCH Publications. All rights reserved. Terms of use.
If you do not wish to receive such mailings in the future please click here to unsubscribe.
Pharmaceutical Press, 66-68 East Smithfield, London, E1W 1AW, United Kingdom.